A comprehensive evaluation of the prognostic relevance of biomarkers such as the ALB concentration and NT-pro BNP level is pivotal for evaluating the overall risk of AF recurrence in patients with HFpEF. The gene discussed is ALB; the disease is atrial fibrillation.